[HTML][HTML] Oral Molnupiravir and Nirmatrelvir/Ritonavir for the Treatment of COVID-19: A Literature Review with a Focus on Real-World Evidence
I Karniadakis, N Mazonakis, C Tsioutis… - Infectious Disease …, 2023 - mdpi.com
Vaccines remain the cornerstone of medical prevention and are highly effective in reducing
the risk of severe disease and death due to coronavirus disease 2019 (COVID-19). In the …
the risk of severe disease and death due to coronavirus disease 2019 (COVID-19). In the …
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in non-hospitalized adults with COVID-19: systematic review and meta-analysis of observational studies
Objective To determine the effectiveness of nirmatrelvir/ritonavir and molnupiravir among
vaccinated and unvaccinated non-hospitalized adults with COVID-19. Methods …
vaccinated and unvaccinated non-hospitalized adults with COVID-19. Methods …
[HTML][HTML] A Multi-Center Study Investigating Long COVID-19 in Healthcare Workers from North-Eastern Italy: Prevalence, Risk Factors and the Impact of Pre-Existing …
L Cegolon, M Mauro, D Sansone, A Tassinari… - Vaccines, 2023 - mdpi.com
Introduction: The impact of long-COVID-19 syndrome is rather variable, since it is influenced
by several residual confounders. This study aimed to investigate the prevalence of long …
by several residual confounders. This study aimed to investigate the prevalence of long …
[HTML][HTML] Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study
Clinical trials demonstrated the role of vaccines and antiviral treatments against SARS-CoV-
2 in reducing the likelihood of disease progression and death. However, there are limited …
2 in reducing the likelihood of disease progression and death. However, there are limited …
[HTML][HTML] Effectiveness and safety of azvudine in COVID-19: A systematic review and meta-analysis
Objective The aim of this study was to assess the effectiveness and safety of azvudine in
treating coronavirus disease 2019 (COVID-19) caused by severe acute respiratory …
treating coronavirus disease 2019 (COVID-19) caused by severe acute respiratory …
COVID-19 in City Council Civil Servants, 1 March 2020–31 January 2023: Risk of Infection, Reinfection, Vaccine Effectiveness and the Impact of Heterologous Triple …
L Cegolon, F Larese Filon - Vaccines, 2024 - mdpi.com
Background: The risk of COVID-19 increases in any occupation entailing intense social
interactions. This study aimed to investigate the impact of COVID-19 among civil servants of …
interactions. This study aimed to investigate the impact of COVID-19 among civil servants of …
[HTML][HTML] Clinical Outcome and 7-Day Virological Clearance in High-Risk Patients with Mild–Moderate COVID-19 Treated with Molnupiravir, Nirmatrelvir/Ritonavir, or …
F Bai, T Beringheli, V Vitaletti, A Santoro, F Molà… - Infectious Diseases and …, 2024 - Springer
Introduction We compared the effectiveness and virological clearance (VC) at day 7 (T7)
post-treatment with molnupiravir, nirmatrelvir/ritonavir, and remdesivir in SARS-CoV-2 …
post-treatment with molnupiravir, nirmatrelvir/ritonavir, and remdesivir in SARS-CoV-2 …
[HTML][HTML] Nirmatrelvir/ritonavir or Molnupiravir for treatment of non-hospitalized patients with COVID-19 at risk of disease progression
AA Butt, P Yan, OS Shaikh - Plos one, 2024 - journals.plos.org
Background In randomized controlled trials, Nirmatrelvir/ritonavir (NMV/r) and Molnupiravir
(MPV) reduced the risk of severe/fatal COVID-19 disease. Real-world data are limited …
(MPV) reduced the risk of severe/fatal COVID-19 disease. Real-world data are limited …
Comparison of effectiveness and safety of molnupiravir versus sotrovimab for COVID‐19: A systematic review and meta‐analysis
Abstract Background and Aim This systematic review and meta‐analysis aimed to compare
the effectiveness and safety of molnupiravir and sotrovimab in the treatment of patients with …
the effectiveness and safety of molnupiravir and sotrovimab in the treatment of patients with …
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis
Background This study aims to compare the effectiveness and safety of nirmatrelvir/ritonavir
(Paxlovid) and sotrovimab for coronavirus disease 2019 (COVID-19). Methods A search was …
(Paxlovid) and sotrovimab for coronavirus disease 2019 (COVID-19). Methods A search was …